Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital — Grand Rapids, Michigan

Public research footprint of Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, compiled from the ClinicalTrials.gov public registry.

169

Registered studies

139

Active

Recruiting now

Completed

Most-studied conditions

B Acute Lymphoblastic Leukemia · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Recurrent Ovarian Carcinoma · EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Recently updated registry entries

NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT07215910 — Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for… (Recruiting)
NCT06064097 — A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.